Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage-Reference-Cited by-同舟云学术

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage

Published:2011-09-08 Issue:4 Volume:23 Page:1475-1480
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Cadarette S. M.,Carney G.,Baek D.,Gunraj N.,Paterson J. M.,Dormuth C. R.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://www.springerlink.com/index/pdf/10.1007/s00198-011-1771-2

Reference11 articles.

1. Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J 182:1864–1873

2. MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213

3. Cranney A, Guyatt G, Griffith L et al (2002) IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578

4. Osteoporosis Canada Provincial Drug Coverage Chart. http://www.osteoporosis.ca/index.php/ci_id/9046/la_id.htm . Accessed 11 Jan 2011

5. Ontario Ministry of Health and Long-Term Care Formulary Search: Ontario Drug Benefit Formulary/Comparative Drug Index. https://www.healthinfo.moh.gov.on.ca/formulary/index.jsp . Accessed 11 Jan 2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates;BMJ;2024-08-21

2. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications;Bone Reports;2024-03

3. Commentary: Zebrafish as a Model for Osteoporosis—An Approach to Accelerating Progress in Drug and Exercise-Based Treatment;International Journal of Environmental Research and Public Health;2022-11-29

4. Use of an electronic medical record dashboard to identify gaps in osteoporosis care;Archives of Osteoporosis;2021-04-24

5. Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use;Osteoporosis International;2021-01-07